Cargando…

Application and comparison of different implanted ports in malignant tumor patients

BACKGROUND: The current study aims to compare the application and convenience of the upper arm port with the other two methods of implanted ports in the jugular vein and the subclavian vein in patients with gastrointestinal cancers. METHODS: Currently, the standard of practice is placement of centra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanhong, Cai, Yonghua, Gan, Xiaoqin, Ye, Xinmei, Ling, Jiayu, Kang, Liang, Ye, Junwen, Zhang, Xingwei, Zhang, Jianwei, Cai, Yue, Hu, Huabin, Huang, Meijin, Deng, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035459/ https://www.ncbi.nlm.nih.gov/pubmed/27664131 http://dx.doi.org/10.1186/s12957-016-1002-6

Ejemplares similares

Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients
por: Li, Jianxia, et al.
Publicado: (2020)

Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study
por: Zhang, Jianwei, et al.
Publicado: (2015)

Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence – A retrospective single-center study
por: Deng, Yanhong, et al.
Publicado: (2015)

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor
por: Ling, Jiayu, et al.
Publicado: (2023)

mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial
por: Shen, Cailu, et al.
Publicado: (2022)

Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
por: Cheng, Yi, et al.
Publicado: (2022)

The prognostic and predictive value of mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy
por: Wu, Zehua, et al.
Publicado: (2022)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial
por: Hu, Huabin, et al.
Publicado: (2018)

Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab
por: Zhang, Jianwei, et al.
Publicado: (2019)

Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer
por: Wu, Zehua, et al.
Publicado: (2018)

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients
por: Lan, Yingxia, et al.
Publicado: (2023)

Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer
por: Wu, Zehua, et al.
Publicado: (2023)

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023)

Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study
por: Zhang, Yuting, et al.
Publicado: (2022)

Ultrasound-guided totally implantable venous access ports via the right innominate vein: a new approach for patients with breast cancer
por: Xu, Liang, et al.
Publicado: (2019)

Perioperative and Postoperative Complications of Ultrasound-Guided Totally Implantable Venous Access Ports via the Brachiocephalic Vein in Patients with Cancer: A Prospective Study
por: Sun, Xingwei, et al.
Publicado: (2021)

Complications after implantation of subcutaneous central venous ports (PowerPort(Ⓡ))
por: Nakamura, Takatoshi, et al.
Publicado: (2017)

Construction and Application of a Comprehensive Evaluation and Assessment System for Clinical Nurses Based on the Support of an Information Technology Platform
por: Luo, BaoPing, et al.
Publicado: (2022)

Intelligent Internet of Things Medical Technology in Implantable Intravenous Infusion Port in Children with Malignant Tumors
por: Liu, Shaohong, et al.
Publicado: (2021)

Comparison of single utility port video-assisted thoracoscopic surgery (VATS) and three-port VATS for non-small cell lung cancer
por: Ye, Zhongrui, et al.
Publicado: (2019)

Port-Site Metastasis in Gynecological Malignancies
por: Benabou, Kelly, et al.
Publicado: (2021)

Extravasation of chemotherapeutic drug from an implantable intravenous infusion port in a child: A case report
por: Lv, Dan-Ni, et al.
Publicado: (2021)

Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients
por: Ruan, Xingya, et al.
Publicado: (2020)

Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study
por: Yu, Zepeng, et al.
Publicado: (2021)

Current port maintenance strategies are insufficient: View based on actual presentations of implanted ports
por: Chou, Pin-Li, et al.
Publicado: (2019)

Retracted: Intelligent Internet of Things Medical Technology in Implantable Intravenous Infusion Port in Children with Malignant Tumors
por: Healthcare Engineering, Journal of
Publicado: (2023)

Depression and Severity Detection Based on Body Kinematic Features: Using Kinect Recorded Skeleton Data of Simple Action
por: Yu, Yanhong, et al.
Publicado: (2022)

A totally implantable venous access port associated with bloodstream infection caused by Mycobacterium fortuitum: A case report
por: YE, Huifen, et al.
Publicado: (2018)

Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
por: Liu, Ye, et al.
Publicado: (2020)

Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study
por: Li, Yong, et al.
Publicado: (2021)

Femoral Access for Central Venous Port System Implantation
por: Cherkashin, Mikhail, et al.
Publicado: (2018)

Utility of totally implantable venous access ports in patients with breast cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Comment on: Simple implantation is safe for patients with totally implantable venous access ports
por: Becker, Felix, et al.
Publicado: (2021)

An analysis of the outcomes of totally implantable access port implantation performed by surgical residents
por: Jeon, Se-Beom, et al.
Publicado: (2021)

Initial experience of single-incision plus one port total laparoscopic pancreaticoduodenectomy
por: Cai, He, et al.
Publicado: (2023)

m(6)A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways
por: Deng, Ru, et al.
Publicado: (2019)

Gastrointestinal stromal tumor metastasis at the site of a totally implantable venous access port insertion: A rare case report
por: Yin, Xiao-Nan, et al.
Publicado: (2020)

Usefulness of peripherally inserted central catheter port system (PICC-PORT) implantation in the sitting position: a new technique for cases unsuitable for conventional implantation
por: Narita, Akiko, et al.
Publicado: (2022)

A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients: Prolonged versus short flushing intervals
por: Zhang, Yuejiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s526iria0q12mat627ftqmbe4n